AJOONI BIOTECH LIMITED
Regd. Office: D-118, Industrial Area, Phase VII, Mohali-160055 (Pb.)
Phone: 0172-5020758-69 Website: www.ajoonibiotech.com
E-mail: ajooni.biotech@gmail.com / info@ajoonibiotech.com
CIN: L85190PB2010PLC040162
December 12, 2022
To,
National Stock Exchange of India Ltd
Exchange Plaza, Plot no. C/1, G Block,
Bandra-Kurla Complex, Bandra (E)
Mumbai - 400051
Dear Sir / Madam,
Subject:Reply to Observations to your e-mail dated 12th December 2022
SYMBOL: AJOONI
Dear Sir/Madam,
This is with reference to your e-mail dated 12th December 2022 regarding Observation Remark in respect to Outcome of Board Meeting submitted to the Exchange dated 11-Nov-2022. Kindly note that in this regard, quarterly and half year ended un-audited financial statements were submitted successfully by the company on 11/11/2022.
We regret to inform you that due to an inadvertent error cash flow statement in this regard was not attached. Further, we are attaching herewith Cash Flow Statement with un-audited results for half year ended 30th September 2022.
You are requested to kindly take the same on your record and acknowledge receipt.
Thanking You,
Yours Truly,
For Ajooni Biotech Limited
JASJOT
SINGH
Jasjot Singh
Managing Director
DIN: 01937631
Digitally signed by JASJOT SINGH Date: 2022.12.12 16:23:36 +05'30'
Works: G.T. Road, Khanna- 141401 (Punjab) INDIA
SWATIDigitally signed by SWATI VIJAN VIJAN Date: 2022.11.11 12:06:05 +05'30'
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Ajooni Biotech Ltd. published this content on 13 December 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 December 2022 08:14:03 UTC.